Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Gething

Showing results (71-80 of 97) with videos related to

Pageof 10
Sort By:
The Biochemical Journal|June 23, 1999
Processing of normal lysosomal and mutant N-acetylgalactosamine 4-sulphatase: BiP (immunoglobulin heavy-chain binding protein) may interact with critical protein contact sitesT M Bradford, M J Gething, R Davey, et al.
The Journal of Biological Chemistry|October 3, 1998
Substrate binding induces depolymerization of the C-terminal peptide binding domain of murine GRP78/BiPM Chevalier, L King, C Wang, et al.
Cell|May 4, 1990
The expression of influenza virus hemagglutinin in the pancreatic beta cells of transgenic mice results in autoimmune diabetesL M Roman, L F Simons, R E Hammer, et al.
The Journal of Biological Chemistry|December 15, 1990
Restoration of serine protease-inhibitor interaction by protein engineeringE L Madison, E J Goldsmith, M J Gething, et al.
Nature|June 29, 1989
Serpin-resistant mutants of human tissue-type plasminogen activatorE L Madison, E J Goldsmith, R D Gerard, et al.
The Biochemical Journal|September 15, 1994
Expression of lactase-phlorizin hydrolase in sheep is regulated at the RNA levelS W Lacey, H Y Naim, R R Magness, et al.
The Biochemical Journal|August 15, 1992
Cell-free synthesis of enzymically active tissue-type plasminogen activator. Protein folding determines the extent of N-linked glycosylationN J Bulleid, R S Bassel-Duby, R B Freedman, et al.
Molecular and Cellular Biology|September 1, 1990
The Saccharomyces cerevisiae DPM1 gene encoding dolichol-phosphate-mannose synthase is able to complement a glycosylation-defective mammalian cell lineP J Beck, P Orlean, C Albright, et al.
Immunological Reviews|August 1, 1987
Antigen presentation pathways to class I and class II MHC-restricted T lymphocytesT J Braciale, L A Morrison, M T Sweetser, et al.
Thrombosis and Haemostasis|January 1, 1994
Inhibitor-resistant tissue-type plasminogen activator: an improved thrombolytic agent in vitroR V Shohet, S Spitzer, E L Madison, et al.
Pageof 10

Showing results (71-80 of 97) with videos related to

Sort By:
Pageof 10
The Biochemical Journal|June 23, 1999
Processing of normal lysosomal and mutant N-acetylgalactosamine 4-sulphatase: BiP (immunoglobulin heavy-chain binding protein) may interact with critical protein contact sitesT M Bradford, M J Gething, R Davey, et al.
The Journal of Biological Chemistry|October 3, 1998
Substrate binding induces depolymerization of the C-terminal peptide binding domain of murine GRP78/BiPM Chevalier, L King, C Wang, et al.
Cell|May 4, 1990
The expression of influenza virus hemagglutinin in the pancreatic beta cells of transgenic mice results in autoimmune diabetesL M Roman, L F Simons, R E Hammer, et al.
The Journal of Biological Chemistry|December 15, 1990
Restoration of serine protease-inhibitor interaction by protein engineeringE L Madison, E J Goldsmith, M J Gething, et al.
Nature|June 29, 1989
Serpin-resistant mutants of human tissue-type plasminogen activatorE L Madison, E J Goldsmith, R D Gerard, et al.
The Biochemical Journal|September 15, 1994
Expression of lactase-phlorizin hydrolase in sheep is regulated at the RNA levelS W Lacey, H Y Naim, R R Magness, et al.
The Biochemical Journal|August 15, 1992
Cell-free synthesis of enzymically active tissue-type plasminogen activator. Protein folding determines the extent of N-linked glycosylationN J Bulleid, R S Bassel-Duby, R B Freedman, et al.
Molecular and Cellular Biology|September 1, 1990
The Saccharomyces cerevisiae DPM1 gene encoding dolichol-phosphate-mannose synthase is able to complement a glycosylation-defective mammalian cell lineP J Beck, P Orlean, C Albright, et al.
Immunological Reviews|August 1, 1987
Antigen presentation pathways to class I and class II MHC-restricted T lymphocytesT J Braciale, L A Morrison, M T Sweetser, et al.
Thrombosis and Haemostasis|January 1, 1994
Inhibitor-resistant tissue-type plasminogen activator: an improved thrombolytic agent in vitroR V Shohet, S Spitzer, E L Madison, et al.
Pageof 10